We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Drug Weekly
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Device Weekly
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Resources
Form 483s Database
FDA Approved Drugs
White Papers
CenterWatch
About Us
The Company
FDAnews Editorial Board
Contact Us
Advertising
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Ronald Ifraimov
Ronald Ifraimov
Products
PRODUCTS
US Infusion, Inc.
Ronald Ifraimov
Price:
$117.00
View
Silq Technologies Corp.
Ronald Ifraimov
Price:
$117.00
View
Lummacups, LLC
Ronald Ifraimov
Price:
$117.00
View
Guard Medical, Inc.
Ronald Ifraimov
Price:
$117.00
View
Natech Plastics, Inc.
Ronald Ifraimov
Price:
$117.00
View
DuoProSS Meditech Corp.
Ronald Ifraimov
Price:
$117.00
View
Kem Medical Products Corp.
Ronald Ifraimov
Price:
$117.00
View
Wound Healing Technologies
Ronald Ifraimov
Price:
$117.00
View
Wound Healing Technologies
Ronald Ifraimov
Price:
$117.00
View
Surimac Manufacturing, Inc.
Ronald Ifraimov
Price:
$117.00
View
View All Products by Ronald Ifraimov
Upcoming Events
11
Oct
GMP Quality Management vSummit 2023: Where Quality Meets Risk
16
Oct
MAGI@home Clinical Research Conference 2023
26
Oct
FDA in 2024: What to Expect in an Election Year
02
Nov
How UDI and UDI Data Can — and Must — Be Used for More Than Just Device Identification
08
Nov
18th Annual FDA Inspections vSummit
Featured Products
FDA, FTC and DOJ Enforcement of Medical Device Regulations
Using Real-World Evidence in Drug and Device Submissions
Featured Stories
Survey Shows Nearly All Pharm Techs Face Drug Shortages, Pfizer Plant Shortages Continue Until 2024
FDA Shares Premarket Requirements for Device Cybersecurity in Final Guidance
Potential Penalties Force BMS to Sign Drug Price Negotiation Agreement With CMS
Despite AdComm Endorsement, neffy Nasal Spray Alternate for EpiPen Gets CRL
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
